Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis.

Noguchi, Hiromitsu; Matsumoto, Tadahiko; Kimura, Utako; Hiruma, Masataro; Kano, Rui; Yaguchi, Takashi; Kubo, Masahide; Kashiwada-Nakamura, Kayo; Fukushima, Satoshi

Noguchi, Hiromitsu; Matsumoto, Tadahiko; Kimura, Utako; Hiruma, Masataro; Kano, Rui; Yaguchi, Takashi; Kubo, Masahide; Kashiwada-Nakamura, Kayo; Fukushima, Satoshi.

Affiliation

Noguchi H; Noguchi Dermatology Clinic, Kumamoto, Japan.
Matsumoto T; Ochanomizu Institute for Medical Mycology and Allergology, Tokyo, Japan.
Kimura U; Noguchi Dermatology Clinic, Kumamoto, Japan.
Hiruma M; Ochanomizu Institute for Medical Mycology and Allergology, Tokyo, Japan.
Kano R; Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yaguchi T; Ochanomizu Institute for Medical Mycology and Allergology, Tokyo, Japan.
Kubo M; Department of Veterinary Dermatology, Nihon University College of Bioresource Sciences, Kanagawa, Japan.
Kashiwada-Nakamura K; Division of Bio-Resources, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Fukushima S; Japan Community Health Care Organization Kumamoto General Hospital, Kumamoto, Japan.

J Dermatol ; 49(5): 564-571, 2022 May.

Article de En | MEDLINE | ID: mdl-35218073

Sujet(s)
Mots clés

Exophiala jeanselmei; Exophiala oligosperma; azoles; fosravuconazole; itraconazole; phaeohyphomycosis; terbinafine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Exophiala / Phaeohyphomycose Type d'étude: Diagnostic_studies Limites: Humans Langue: En Journal: J Dermatol Année: 2022 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google